TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Sequential Versus Concurrent Use of Vaginal Misoprostol Plus Foley Catheter for Induction of Labor
Brief Summary: to compare between sequential and concurrent use of vaginal misopristol plus foleys catheter for induction of labor


Options:
A: Arm Label: Oxytocin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxytocin | Arm Label: Foley Catheter and Oxytocin; Type: EXPERIMENTAL; Interventions: Device: Foley Catheter, Drug: Oxytocin | Intervention Type: DEVICE; Name: Foley Catheter; Assigned to Arm(s): Foley Catheter and Oxytocin | Intervention Type: DRUG; Name: Oxytocin; Assigned to Arm(s): Foley Catheter and Oxytocin, Oxytocin
B: Arm Label: misoprostol group; Type: ACTIVE_COMPARATOR; Interventions: Device: misoprostol | Arm Label: misoprostol and foley bulb group; Type: ACTIVE_COMPARATOR; Interventions: Device: misoprostol, Device: Foley bulb | Intervention Type: DEVICE; Name: misoprostol; Assigned to Arm(s): misoprostol and foley bulb group, misoprostol group | Intervention Type: DEVICE; Name: Foley bulb; Assigned to Arm(s): misoprostol and foley bulb group
C: Arm Label: Cervical foley & Misoprostol; Type: EXPERIMENTAL; Interventions: Device: Cervical Foley & Misoprostol | Arm Label: Misoprostol only; Type: EXPERIMENTAL; Interventions: Drug: Misoprostol Alone | Arm Label: Cervical foley alone; Type: EXPERIMENTAL; Interventions: Device: Cervical Foley Alone | Arm Label: Cervical foley & Pitocin; Type: EXPERIMENTAL; Interventions: Device: Cervical Foley & Pitocin | Intervention Type: DEVICE; Name: Cervical Foley & Misoprostol; Assigned to Arm(s): Cervical foley & Misoprostol | Intervention Type: DRUG; Name: Misoprostol Alone; Assigned to Arm(s): Misoprostol only | Intervention Type: DEVICE; Name: Cervical Foley Alone; Assigned to Arm(s): Cervical foley alone | Intervention Type: DEVICE; Name: Cervical Foley & Pitocin; Assigned to Arm(s): Cervical foley & Pitocin
D: Arm Label: sequential; Type: ACTIVE_COMPARATOR; Interventions: Drug: Misoprostol, Device: Foley Catheter | Arm Label: Concurrent; Type: ACTIVE_COMPARATOR; Interventions: Drug: Misoprostol, Device: Foley Catheter | Intervention Type: DRUG; Name: Misoprostol; Assigned to Arm(s): Concurrent, sequential | Intervention Type: DEVICE; Name: Foley Catheter; Assigned to Arm(s): Concurrent, sequential

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Sequential Versus Concurrent Use of Vaginal Misoprostol Plus Foley Catheter for Induction of Labor
Brief Summary: to compare between sequential and concurrent use of vaginal misopristol plus foleys catheter for induction of labor


Options:
A: Arm Label: Misoprostol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Misoprostol | Arm Label: Foley Catheter; Type: ACTIVE_COMPARATOR; Interventions: Device: Foley Catheter | Intervention Type: DEVICE; Name: Foley Catheter; Assigned to Arm(s): Foley Catheter | Intervention Type: DRUG; Name: Misoprostol; Assigned to Arm(s): Misoprostol
B: Arm Label: sequential; Type: ACTIVE_COMPARATOR; Interventions: Drug: Misoprostol, Device: Foley Catheter | Arm Label: Concurrent; Type: ACTIVE_COMPARATOR; Interventions: Drug: Misoprostol, Device: Foley Catheter | Intervention Type: DRUG; Name: Misoprostol; Assigned to Arm(s): Concurrent, sequential | Intervention Type: DEVICE; Name: Foley Catheter; Assigned to Arm(s): Concurrent, sequential
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: misoprostol | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: dinoprostone | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Device: Bard Catheter (balloon catheter) | Intervention Type: DRUG; Name: misoprostol; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: dinoprostone; Assigned to Arm(s): 2 | Intervention Type: DEVICE; Name: Bard Catheter (balloon catheter); Assigned to Arm(s): 3
D: Arm Label: Mechanical cervical ripening; Type: EXPERIMENTAL; Interventions: Device: Mechanical cervical ripening | Arm Label: Pharmacological cervical ripening; Type: ACTIVE_COMPARATOR; Interventions: Drug: Pharmacological cervical ripening | Intervention Type: DEVICE; Name: Mechanical cervical ripening; Assigned to Arm(s): Mechanical cervical ripening | Intervention Type: DRUG; Name: Pharmacological cervical ripening; Assigned to Arm(s): Pharmacological cervical ripening

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effect of Glycopyrronium and Indacaterol, as Monotherapy and in Combination, on the Methacholine Dose-response Curve
Brief Summary: The study will assess the effects of two drugs, glycopyrronium and indacaterol, taken either as monotherapy or in combination, on the methacholine dose-response curve. This will allow for further elucidation of the mechanisms of each drug in human participants.


Options:
A: Arm Label: LAMA Treatment; Type: EXPERIMENTAL; Interventions: Drug: Glycopyrronium | Arm Label: uLABA Treatment; Type: EXPERIMENTAL; Interventions: Drug: Indacaterol | Arm Label: Combo Treatment; Type: EXPERIMENTAL; Interventions: Drug: Glycopyrronium, Drug: Indacaterol | Intervention Type: DRUG; Name: Glycopyrronium; Assigned to Arm(s): Combo Treatment, LAMA Treatment | Intervention Type: DRUG; Name: Indacaterol; Assigned to Arm(s): Combo Treatment, uLABA Treatment
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: budesonide/formoterol | Arm Label: 2; Type: SHAM_COMPARATOR; Interventions: Drug: Symbicort pMDI + budesonide HFA pMDI | Intervention Type: DRUG; Name: budesonide/formoterol; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Symbicort pMDI + budesonide HFA pMDI; Assigned to Arm(s): 2
C: Arm Label: Fluticasone Furoate/Vilanterol; Type: EXPERIMENTAL; Interventions: Drug: Fluticasone Furoate/Vilanterol Inhalation Powder, Other: Placebo Inhalation Powder 2 | Arm Label: Fluticasone Furoate; Type: ACTIVE_COMPARATOR; Interventions: Drug: Fluticasone Furoate Inhalation Powder, Other: Placebo Inhalation Powder 2 | Arm Label: Fluticasone Propionate; Type: ACTIVE_COMPARATOR; Interventions: Drug: Fluticasone Propionate Inhalation Powder, Other: Placebo Inhalation Powder 1 | Intervention Type: DRUG; Name: Fluticasone Furoate/Vilanterol Inhalation Powder; Assigned to Arm(s): Fluticasone Furoate/Vilanterol | Intervention Type: DRUG; Name: Fluticasone Furoate Inhalation Powder; Assigned to Arm(s): Fluticasone Furoate | Intervention Type: DRUG; Name: Fluticasone Propionate Inhalation Powder; Assigned to Arm(s): Fluticasone Propionate | Intervention Type: OTHER; Name: Placebo Inhalation Powder 1; Assigned to Arm(s): Fluticasone Propionate | Intervention Type: OTHER; Name: Placebo Inhalation Powder 2; Assigned to Arm(s): Fluticasone Furoate, Fluticasone Furoate/Vilanterol
D: Arm Label: CHF 5993 200/6/12.5 µg; Type: EXPERIMENTAL; Interventions: Drug: CHF 5993 200/6/12.5 µg | Arm Label: CHF 1535 200/6 µg; Type: ACTIVE_COMPARATOR; Interventions: Drug: CHF 1535 200/6 µg | Arm Label: CHF 1535 200/6 µg + Tiotropium Respimat 2.5 µg; Type: ACTIVE_COMPARATOR; Interventions: Drug: CHF 1535 200/6 µg + Tiotropium Respimat 2.5 µg | Intervention Type: DRUG; Name: CHF 5993 200/6/12.5 µg; Assigned to Arm(s): CHF 5993 200/6/12.5 µg | Intervention Type: DRUG; Name: CHF 1535 200/6 µg; Assigned to Arm(s): CHF 1535 200/6 µg | Intervention Type: DRUG; Name: CHF 1535 200/6 µg + Tiotropium Respimat 2.5 µg; Assigned to Arm(s): CHF 1535 200/6 µg + Tiotropium Respimat 2.5 µg

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Once-daily Regimen With Envarsus® to Optimize Immunosuppression Management and Outcomes in Kidney Transplant Recipients
Brief Summary: With the availability of well-studied once-daily formulations of tacrolimus, the ability to achieve a true once-daily immunosuppressant regimen along with everolimus and steroids may finally be achievable and have the potential to optimize immunosuppression safety and efficacy in kidney transplantation.


Options:
A: Arm Label: 1 with pharmaceutical intervention; Type: EXPERIMENTAL; Interventions: Other: Pharmaceutical Intervention | Arm Label: 2 without pharmaceutical intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Pharmaceutical Intervention; Assigned to Arm(s): 1 with pharmaceutical intervention
B: Arm Label: SystemCHANGE; Type: EXPERIMENTAL; Interventions: Behavioral: SystemCHANGE | Arm Label: Patient-education attention-control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Patient-education attention control | Intervention Type: BEHAVIORAL; Name: SystemCHANGE; Assigned to Arm(s): SystemCHANGE | Intervention Type: BEHAVIORAL; Name: Patient-education attention control; Assigned to Arm(s): Patient-education attention-control
C: Arm Label: Tacrolimus + MMF; Type: ACTIVE_COMPARATOR; Interventions: Drug: Tacrolimus, Drug: Prednisone, Drug: Mycophenolate mofetil | Arm Label: Envarsus + Everolimus; Type: ACTIVE_COMPARATOR; Interventions: Drug: Tacrolimus, Drug: Prednisone, Drug: Everolimus | Intervention Type: DRUG; Name: Tacrolimus; Assigned to Arm(s): Envarsus + Everolimus, Tacrolimus + MMF | Intervention Type: DRUG; Name: Prednisone; Assigned to Arm(s): Envarsus + Everolimus, Tacrolimus + MMF | Intervention Type: DRUG; Name: Mycophenolate mofetil; Assigned to Arm(s): Tacrolimus + MMF | Intervention Type: DRUG; Name: Everolimus; Assigned to Arm(s): Envarsus + Everolimus
D: Arm Label: Standard of Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: mHealth Intervention; Type: EXPERIMENTAL; Interventions: Other: mHealth Intervention | Intervention Type: OTHER; Name: mHealth Intervention; Assigned to Arm(s): mHealth Intervention

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Prevention Of Delirium in Elderly With Obstructive Sleep Apnea (PODESA)
Brief Summary: Delirium is a common complication in elderly patients following surgery. Patients who develop delirium after surgery are at increased risk for serious complications, and even death.This multi-centre randomized controlled trial will enroll elderly patients scheduled for elective hip/knee replacement surgery.The objective of this trial is to identify obstructive sleep apnea using ApneaLink Air and to determine whether auto-titrating CPAP treatment of obstructive sleep apnea will decrease the incidence of post-operative delirium in elderly patients undergoing elective hip and knee replacement surgery.


Options:
A: Arm Label: Care as usual; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Dementia Care Management (DCM); Type: EXPERIMENTAL; Interventions: Behavioral: Dementia Care Management (DCM) | Intervention Type: BEHAVIORAL; Name: Dementia Care Management (DCM); Assigned to Arm(s): Dementia Care Management (DCM)
B: Arm Label: Liberal (10 g/dL) Transfusion Strategy; Type: EXPERIMENTAL; Interventions: Biological: Liberal (10 g/dL) Transfusion Strategy | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Biological: Restrictive (Symptomatic) Transfusion Strategy | Intervention Type: BIOLOGICAL; Name: Liberal (10 g/dL) Transfusion Strategy; Assigned to Arm(s): Liberal (10 g/dL) Transfusion Strategy | Intervention Type: BIOLOGICAL; Name: Restrictive (Symptomatic) Transfusion Strategy; Assigned to Arm(s): 2
C: Arm Label: CPAP therapy arm; Type: EXPERIMENTAL; Interventions: Other: CPAP treatment | Arm Label: Control arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: CPAP treatment; Assigned to Arm(s): CPAP therapy arm
D: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: Group-based exercise training during hospitalization | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Group-based exercise training during hospitalization; Assigned to Arm(s): Intervention

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Prevention Of Delirium in Elderly With Obstructive Sleep Apnea (PODESA)
Brief Summary: Delirium is a common complication in elderly patients following surgery. Patients who develop delirium after surgery are at increased risk for serious complications, and even death.This multi-centre randomized controlled trial will enroll elderly patients scheduled for elective hip/knee replacement surgery.The objective of this trial is to identify obstructive sleep apnea using ApneaLink Air and to determine whether auto-titrating CPAP treatment of obstructive sleep apnea will decrease the incidence of post-operative delirium in elderly patients undergoing elective hip and knee replacement surgery.


Options:
A: Intervention Type: PROCEDURE; Name: Orthogeriatric intervention; Assigned to Arm(s): N/A
B: Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard non-pharmacological prevention intervention | Arm Label: Treatment; Type: EXPERIMENTAL; Interventions: Behavioral: Occupational therapy intervention, Behavioral: Standard non-pharmacological prevention intervention | Intervention Type: BEHAVIORAL; Name: Occupational therapy intervention; Assigned to Arm(s): Treatment | Intervention Type: BEHAVIORAL; Name: Standard non-pharmacological prevention intervention; Assigned to Arm(s): Control, Treatment
C: Arm Label: Fam-FFC; Type: EXPERIMENTAL; Interventions: Behavioral: Family-centered Function-focused Care (Fam-FFC) | Arm Label: Attention Control (Fam- FFC Ed-only); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Family-centered Function-focused Care (Fam-FFC); Assigned to Arm(s): Fam-FFC
D: Arm Label: CPAP therapy arm; Type: EXPERIMENTAL; Interventions: Other: CPAP treatment | Arm Label: Control arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: CPAP treatment; Assigned to Arm(s): CPAP therapy arm

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Influence of Moment of Systemic Metronidazole and Amoxicillin Administration in the Treatment of Chronic Periodontitis: a Randomized Clinical Trial.
Brief Summary: The aim of this multicenter randomized clinical trial is to compare the clinical, microbiological and immunological effects of the adjunctive use of systemic metronidazole plus amoxicillin administered in different phases of the treatment of generalized chronic periodontitis.


Options:
A: Arm Label: Scaling and root planing alone; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Scaling and root planing | Arm Label: SRP + Metronidazole; Type: ACTIVE_COMPARATOR; Interventions: Drug: Metronidazole | Arm Label: SRP + MET + Amoxicillin + Doxycycline; Type: ACTIVE_COMPARATOR; Interventions: Drug: Amoxicillin, Drug: Doxycycline | Intervention Type: PROCEDURE; Name: Scaling and root planing; Assigned to Arm(s): Scaling and root planing alone | Intervention Type: DRUG; Name: Metronidazole; Assigned to Arm(s): SRP + Metronidazole | Intervention Type: DRUG; Name: Amoxicillin; Assigned to Arm(s): SRP + MET + Amoxicillin + Doxycycline | Intervention Type: DRUG; Name: Doxycycline; Assigned to Arm(s): SRP + MET + Amoxicillin + Doxycycline
B: Arm Label: Periodontal intervention, sugar pill; Type: PLACEBO_COMPARATOR; Interventions: Drug: Metronidazol | Intervention Type: DRUG; Name: Metronidazol; Assigned to Arm(s): Periodontal intervention, sugar pill
C: Arm Label: Moxifloxacin; Type: EXPERIMENTAL; Interventions: Drug: moxifloxacin | Arm Label: Ciprofloxacin plus metronidazole; Type: ACTIVE_COMPARATOR; Interventions: Drug: Ciprofloxacin plus metronidazole | Intervention Type: DRUG; Name: moxifloxacin; Assigned to Arm(s): Moxifloxacin | Intervention Type: DRUG; Name: Ciprofloxacin plus metronidazole; Assigned to Arm(s): Ciprofloxacin plus metronidazole
D: Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Scaling and root planing, Drug: Placebos active phase, Drug: Placebos healing phase | Arm Label: Active phase; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Scaling and root planing, Drug: Metronidazole active phase, Drug: Amoxicillin active phase, Drug: Placebos healing phase | Arm Label: Healing phase; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Scaling and root planing, Drug: Metronidazole healing phase, Drug: Amoxicillin healing phase, Drug: Placebos active phase | Intervention Type: PROCEDURE; Name: Scaling and root planing; Assigned to Arm(s): Active phase, Control, Healing phase | Intervention Type: DRUG; Name: Metronidazole active phase; Assigned to Arm(s): Active phase | Intervention Type: DRUG; Name: Metronidazole healing phase; Assigned to Arm(s): Healing phase | Intervention Type: DRUG; Name: Amoxicillin active phase; Assigned to Arm(s): Active phase | Intervention Type: DRUG; Name: Amoxicillin healing phase; Assigned to Arm(s): Healing phase | Intervention Type: DRUG; Name: Placebos active phase; Assigned to Arm(s): Control, Healing phase | Intervention Type: DRUG; Name: Placebos healing phase; Assigned to Arm(s): Active phase, Control

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effects of Video-Based Task Oriented Activity Training on Activity Performance and Participation in Patients With Juvenile Idiopathic Arthritis
Brief Summary: Juvenile idiopathic arthritis (JIA) is most common chronic rheumatic disease in childhood. The upper extremity involvement in JIA causes muscle imbalance, joint destruction, pain, stiffness and limitations on daily living activities (DLA) in varying degrees. However, the information about prevalence of symptoms, disorders, DLA limitations, participation restriction and options of treatments for upper extremity involvement in JIA are limited. It has been reported that improvements of upper extremity functions were achieved by video-based games (VBG) in various disease groups. However, in the literature, no study has been found about effectiveness of WBG in children with arthritis. The aim of the study was to investigate effects of task-oriented activity training (TOAT) with VBG versus activity training in real life on activity performance and participation in children with arthritis. Participants with upper limb involvement in JIA were randomly assigned to the activity training in real life group (group I) and TOAT with VBG in real life group (group II). The actual materials and rehabilitation kits will be used for activity training in group 1, the DLA that expected to gain independence will be trained with VBG in group 2. Upper extremity muscle strength and grip, range of motion, upper limb functions, activity, participation and quality of life will be evaluated. The hypothesis of this study is that TOAT with VBG improves the activity performance and physical functions and increases the participation, via being stimulative and interactive in order to provide feedback and to increase interest and motivation.


Options:
A: Arm Label: Treatment with manipulation; Type: EXPERIMENTAL; Interventions: Procedure: Advice and exercise-based treatment plus joint manipulation | Arm Label: Treatment without manipulation; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Advice and exercise-based treatment | Intervention Type: PROCEDURE; Name: Advice and exercise-based treatment plus joint manipulation; Assigned to Arm(s): Treatment with manipulation | Intervention Type: PROCEDURE; Name: Advice and exercise-based treatment; Assigned to Arm(s): Treatment without manipulation
B: Intervention Type: BEHAVIORAL; Name: Aerobic and Qi gong Exercise; Assigned to Arm(s): N/A
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: activity training | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Other: activity training | Intervention Type: OTHER; Name: activity training; Assigned to Arm(s): 1, 2
D: Arm Label: Chiropractic + Exercise; Type: EXPERIMENTAL; Interventions: Other: Chiropractic + Exercise | Arm Label: Exercise; Type: ACTIVE_COMPARATOR; Interventions: Other: Exercise | Intervention Type: OTHER; Name: Chiropractic + Exercise; Assigned to Arm(s): Chiropractic + Exercise | Intervention Type: OTHER; Name: Exercise; Assigned to Arm(s): Exercise

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Comparison Between Recorded Mother's and Stranger's Voice on the Emergence of General Anesthesia on Pediatric Patients
Brief Summary: Mother spend a large amount of time with their children. It is assumed that mother contributes to their neurological development not only with visual stimuli, but also with auditory stimuli. A recent study revealed that prefrontal cortex can be activated in response to the self-name being spoken by the mother than by a stranger. Therefore, investigators suppose that recorded maternal voice can stimulate the pediatric patients and thereby fasten the emergence from general anesthesia.


Options:
A: Arm Label: Fast injection; Type: EXPERIMENTAL; Interventions: Other: Fast injection speed by immunizer | Arm Label: Slow injection; Type: ACTIVE_COMPARATOR; Interventions: Other: Slow injection speed by immunizer | Intervention Type: OTHER; Name: Fast injection speed by immunizer; Assigned to Arm(s): Fast injection | Intervention Type: OTHER; Name: Slow injection speed by immunizer; Assigned to Arm(s): Slow injection
B: Arm Label: Self-monitoring of BF and intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Self-monitoring of BF and intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Self-monitoring of BF and intervention; Assigned to Arm(s): Self-monitoring of BF and intervention
C: Arm Label: Noanalgesia; Type: SHAM_COMPARATOR; Interventions: Procedure: Water 2mL PO 2 minutes prior to intra-muscular injection | Arm Label: Skin-to-skin; Type: EXPERIMENTAL; Interventions: Procedure: skin-to-skin contact | Arm Label: Glucose; Type: EXPERIMENTAL; Interventions: Procedure: Glucose 25% 2 mL PO 2 minutes prior to injection | Arm Label: Skin&Glucose; Type: EXPERIMENTAL; Interventions: Procedure: neonates will receive skin-to-skin contact beginning 2 minutes after the intra-muscular injection and stopping 2 minutes afterwards. | Intervention Type: PROCEDURE; Name: Water 2mL PO 2 minutes prior to intra-muscular injection; Assigned to Arm(s): Noanalgesia | Intervention Type: PROCEDURE; Name: skin-to-skin contact; Assigned to Arm(s): Skin-to-skin | Intervention Type: PROCEDURE; Name: Glucose 25% 2 mL PO 2 minutes prior to injection; Assigned to Arm(s): Glucose | Intervention Type: PROCEDURE; Name: neonates will receive skin-to-skin contact beginning 2 minutes after the intra-muscular injection and stopping 2 minutes afterwards.; Assigned to Arm(s): Skin&Glucose
D: Arm Label: Group M; Type: EXPERIMENTAL; Interventions: Procedure: recorded maternal voice | Arm Label: Group S; Type: ACTIVE_COMPARATOR; Interventions: Procedure: recorded stranger's voice | Intervention Type: PROCEDURE; Name: recorded maternal voice; Assigned to Arm(s): Group M | Intervention Type: PROCEDURE; Name: recorded stranger's voice; Assigned to Arm(s): Group S

Answer: D